ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Pharmacokinetics and Tolerability of Zavesca® (Miglustat) In Patients With Juvenile GM2 Gangliosidosis

This study is ongoing, but not recruiting participants.
Study NCT00418847.   Last updated on January 4, 2007.   Information provided by The Hospital for Sick Children
Please refer to this study by its ClinicalTrials.gov identifier: NCT00418847


Locations
Canada, Ontario
The Hospital for Sick Children    
      Toronto, Ontario, Canada, M5G 1X8

Sponsors and Collaborators
The Hospital for Sick Children
Actelion

Investigators
Principal Investigator:     Joe TR Clarke, MD     The Hospital for Sick Children, Toronto Canada    


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act
U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services



Links to all studies - primarily for crawlers